Placental Growth Factor in Assessment of Women With Suspected Pre-eclampsia to Reduce Maternal Morbidity: A Stepped Wedge Cluster Randomized Control Trial (PARROT Ireland). Issue 2 (February 2022)

• Record Type: Journal Article
• Authors: Hayes-Ryan, D.; Khashan, A. S.; Hemming, K.; Easter, C.; Devane, D.; Murphy, D. J.; Hunter, A.; Cotter, A.; McAuliffe, F. M.; Morrison, J. J.; Breathnach, F. M.; Dempsey, E.; Kenny, L. C.; O'Donoghue, K.
• Is Part Of: Obstetrical & gynecological survey. Volume 77:Issue 2(2022)
• Publication Date: 2022-02
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000816520.45261.25
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from BMJ 2021;374:n1857) Placental growth factor (PlGF) has been suggested as a diagnostic biomarker of preeclampsia or placental dysfunction. PIGF typically circulates in maternal plasma and increases as placenta develops.